Universe Pharmaceuticals (NYSE:UPC) Stock Price Down 6.1% – Should You Sell?

Universe Pharmaceuticals INC (NYSE:UPC) shares traded down 6.1% during trading on Tuesday . The stock traded as low as $0.14 and last traded at $0.16. 1,806,553 shares changed hands during trading, a decline of 75% from the average session volume of 7,264,415 shares. The stock had previously closed at $0.17.

Universe Pharmaceuticals Trading Down 6.1 %

The stock has a 50-day simple moving average of $0.51 and a two-hundred day simple moving average of $11.92.

Institutional Trading of Universe Pharmaceuticals

A hedge fund recently bought a new stake in Universe Pharmaceuticals stock. Anson Funds Management LP purchased a new stake in Universe Pharmaceuticals INC (NYSE:UPC) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 230,407 shares of the company’s stock, valued at approximately $141,000. Anson Funds Management LP owned approximately 13.40% of Universe Pharmaceuticals as of its most recent filing with the SEC. Institutional investors and hedge funds own 0.18% of the company’s stock.

About Universe Pharmaceuticals

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.